Latvia’s Gamechanger Audio continues to invent wacky, one-of-a-kind pedals, but its new Recorder is so unusual the company still isn’t sure what exactly the pedal is – or could be. Like the weird ...

The trial’s primary efficacy endpoint is AF burden, which refers to the percentage of time a participant is in AF.